Leadership Team

David P. Hochman

Chairman of the Board of Directors and Chief Executive Officer

Mr. Hochman has over 20 years of venture capital and investment banking experience. Since 2007, Mr. Hochman has been Managing Partner of Orchestra Medical Ventures, LLC, an investment firm that employs a strategy to create, build and invest in medical technology companies intended to generate substantial clinical value.

Darren R. Sherman

President, Chief Operating Officer and Director

Mr. Sherman has over 24 years of management and entrepreneurial experience in the medical technology industry spanning interventional cardiology, cardiac electrophysiology, sudden cardiac death, stroke, surgery, GI, and neurovascular therapies.

Yuval Mika, Ph. D.

General Manager and Chief Technology Officer, Cardiac Neuromodulation

Dr. Yuval Mika, Ph.D. was one of the founders of BackBeat and the leader in the development of BackBeat Cardiac Neuromodulation Therapy from concept and design of the device through preclinical and clinical work demonstrating the effect of the therapy in lowering blood pressure. Dr. Mika has 25 years of experience in the medical device industry, bringing technologies from concept to commercialization.

Hikmat Hojeibane

Chief Technology Officer, Vascular Interventions

Mr. Hikmat Hojeibane is an accomplished R&D expert in the medtech industry with in depth knowledge and experience in product development, innovation and regulatory approvals.

William Baumbach, Ph.D.

Chief Scientific Officer, Vascular Interventions

Dr. Baumbach, Ph.D. has over 30 years of experience in pharmaceutical, biotechnology, and medical device R&D. Before co-founding Caliber Therapeutics in 2008, he was the Vice President of Research & Development at X-Cell Medical, a Drug-Eluting Stent startup that was based on a novel therapeutic agent, beta estradiol, that offered an enhanced safety profile.

Eileen Bailey

Vice President of Quality and Regulatory Affairs

Ms. Eileen Bailey will be the Vice President of Quality and Regulatory Affairs for OBIO. Throughout her career, she has had the opportunity to be involved in all aspects of medical device and combination device product development through commercialization.

Michael Harrison, CPA, MST

Interim Chief Financial Officer

Mr. Michael Harrison currently is part of the management team at The CFO Squad (an accounting consulting firm which offers CFO-level talent on an outsourced basis) and serves as Interim CFO for Caliber and BackBeat and will serve as Orchestra Biomed, Inc.’s interim Chief Financial Officer.

Daniel Burkhoff, M.D., PhD.

Chief Scientific Officer, Cardiac Neuromodulation (Consultant)

After earning a Bachelors of Sciences degree from Cornell University in Applied and Engineering Physics, Dr. Daniel Burkhoff, M.D., Ph.D. obtained Doctorate of Philosophy and medical degrees from The Johns Hopkins School of Medicine and completed a fellowship in Cardiology at The Johns Hopkins Hospital.

Steven Evans, M.D.

Chief Medical Officer, Cardiac Neuromodulation (Consultant)

Dr. Steven Evans, M.D. obtained his medical degree from New York University School of Medicine and completed his fellowship in Cardiovascular Disease and Electrophysiology at Cedars-Sinai Hospital.

Norbert Rosenthal

Director, Clinical & Technical Operations, Cardiac Neuromodulation

Since 2013, Mr. Norbert Rosenthal has served as the Clinical Director and Technical Manager of BackBeat Medical, Inc., supporting BackBeat's clinical trials.

Jürgen Bernhard, Ph.D.

Director, Clinical Operation, Cardiac Neuromodulation

Dr. Jürgen Bernhard has over 23 years of medical device experience in the areas of clinical research, marketing and sales leadership.  Dr. Bernhard started his career in clinical research with Biotronik.

Dennis Donohoe, M.D.

Chief Medical Officer, Consultant

Dr. Dennis Donohoe, M.D. currently serves as the Chief Medical Officer for the Vascular Interventions Business Unit.  For the past eight years, Dr. Donohoe has served as clinical and regulatory consultant for a variety of device companies.

Have any questions?
Contact us at 917.254.4900 or info@orchestrabiomed.com